In addition, MBX-8025, an agonist of PPARβ/δ, showed a series of encouraging effects involving decreased levels of γ-glutamyl transpeptidase and alkaline phosphatase, which are indicators of primary biliary cholangitis [147]. This evidence concerns the gene PPARD and primary biliary cholangitis.